BioGaia’s probiotics to be launched in Kenya, Nigeria and Ghana

Published: 14-Sep-2016
Active Nutrition Food

BioGaia ProTectis drops, tablets and oral rehydration solution to be launched in Kenya this year


BioGaia has signed an exclusive distributor agreement with Phillips Pharma Group for the rights to sell BioGaia ProTectis drops, tablets and oral rehydration solution in Kenya, Nigeria and Ghana. The products will be sold under the BioGaia brand and the launch is planned to start in Kenya in 2016.

Phillips Pharma Group was established in Kenya in 1991, focusing on importing, marketing and distributing pharmaceuticals. Today the company has more than 1,000 employees and is present in seven countries around Africa – Kenya, Nigeria, Tanzania, Zambia, Uganda, Rwanda and Ghana – covering 350 million people or 35% of Africa’s population. Among its pharmaceutical partners are international companies such as Novartis, Abbott, Sandoz and Menarini.

'Phillips Pharma Group believes in a long term partnership with BioGaia and is committed to market and position its probiotics as an innovative and premium brand in the market,' says Niraj Doshi, CEO, Phillips Pharma Group. 'The experience we have working close to doctors and specialists will allow us to achieve BioGaia’s expectations and goals.'

'I am very happy that we have signed an agreement that gives BioGaia access to Central and Eastern Africa, a market with large potential for our products,' adds Axel Sjöblad, Managing Director, BioGaia. 'Phillips Pharma Group is a strong and reliable partner with local presence in several important markets and I look forward to a fruitful collaboration.'

  • Companies:
  • BioGaia
  • Phillip Pharma Group
See more

You may also like

Distribution

BioGaia signs major distribution and license agreements with partner in Japan

Read more
Through its Japanese subsidiary, BioGaia has signed two new exclusive distributor agreements for Japan with Nippon Kabaya Ohayo Holdings Inc.

Trending Articles

  1. Mythbusting study highlights the heart health benefits of omega-6 fatty acids A new report has highlighted the benefits of omega-6 intake — specifically linoleic acid — in reducing the risk of cardiovascular disease, type II diabetes and elevated cholesterol levels
  2. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
  3. Solabia Nutrition's Brainberry incorporated into Flow's cognition-supporting functional chocolate Looking past the headlines, NBR find out more about the nootropic, L-theanine and caffeine-boosted functional food and how enhanced sweet treats are impacting the industry
  4. Five key trends in sports nutrition When it comes to meeting the needs of active consumers, says James Street, Global Marketing Director at Prinova, nutrition plays a pivotal role. The right products can improve endurance, build strength, enhance focus, reduce injury risk and speed up recovery times

Upcoming event

Vitafoods India

5–7 February 2025 | Exhibition | Mumbai See all

You may also like

Distribution

BioGaia signs major distribution and license agreements with partner in Japan

Through its Japanese subsidiary, BioGaia has signed two new exclusive distributor agreements for Japan with Nippon Kabaya Ohayo Holdings Inc.
Dietary supplements

BioGaia’s oral health probiotic reduces pregnancy gingivitis

Women with pregnancy gingivitis may be more likely to deliver babies prematurely or with low birth weight than mothers with healthy gums
Ingredients

BioGaia’s probiotic effective in treating abdominal pain in children

Stomach pain is common among children and often affects the child’s daily life through, for example, anxiety and school absenteeism
Regulatory

Yet another meta-analysis confirms the effectiveness of BioGaia’s probiotic in infantile colic

L. reuteri Protectis is effective in reducing crying time in colicky infants
Ingredients

BioGaia’s oral health probiotics to be launched in Hong Kong

BioGaia has signed an exclusive agreement with BioWellTech Co. Ltd for the rights to sell BioGaia ProDentis in Hong Kong
Research & Development

Meta-analysis confirms effectiveness of BioGaia's probiotic for infant colic

The review evaluated 17 studies of different treatments for infant colic
Research & Development

BioGaia’s probiotic shown to promote growth and prevent recurrent diarrhoea

Diarrhoea is the second leading cause of mortality in the world among children under the age of five
Subscribe now